Simcere Pharmaceutical Group Plans to Triple Headcount to 1,000 in New R&D Facility

August 3, 2011 -- Simcere Pharmaceutical will increase its R&D staff to 1,000 in the next three or four years, up from its present headcount of 300. The company recently announced it would build a new R&D center in Beijing's Zhongguancun Innovation Park, where it recently bought rights to 65,300 square meters of land. The company is headquartered in Nanjing, but Simcere said it wanted to access Beijing’s talent pool. The company says its needs R&D to increase its product portfolio. More details....

Stock Symbol: (NYSE: SCR)